glutamine has been researched along with oxyntomodulin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blazquez, E; Calvo, JC; Gisolfi, CV; Mora, F | 1 |
| Adrian, TE; Arnelo, U; Larsson, J; Permert, J; Staab, P; Wirén, M | 2 |
| Goto, N; Kameyama, T; Oka, JI | 1 |
| Scolapio, JS | 1 |
| Clandinin, MT; Drozdowski, L; Iordache, C; Keelan, M; Neo, CC; Thiesen, A; Thomson, AB; Wild, G; Woudstra, TD; Xenodemetropoulos, T | 1 |
| Leiss, O | 1 |
| Jeppesen, PB | 1 |
4 review(s) available for glutamine and oxyntomodulin
| Article | Year |
|---|---|
Treatment of short-bowel syndrome.
Topics: Animals; Colon; Dietary Carbohydrates; Disease Models, Animal; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Glutamine; Growth Substances; Humans; Intestine, Small; Peptides; Short Bowel Syndrome | 2001 |
Adaptation following intestinal resection: mechanisms and signals.
Topics: Animals; Biomarkers; Disease Models, Animal; Epidermal Growth Factor; Glucagon-Like Peptides; Glucocorticoids; Glutamine; Growth Hormone; Humans; Insulin-Like Growth Factor I; Intestinal Absorption; Intestinal Mucosa; Intestines; Peptides; Short Bowel Syndrome | 2003 |
[Clinical management of patients with short bowel syndrome].
Topics: Combined Modality Therapy; Enteral Nutrition; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Glutamine; Growth Hormone; Humans; Intestinal Absorption; Jejunostomy; Oxalates; Parenteral Nutrition, Total; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Short Bowel Syndrome; Treatment Outcome; Water-Electrolyte Balance | 2005 |
The use of hormonal growth factors in the treatment of patients with short-bowel syndrome.
Topics: Body Composition; Body Weight; Creatinine; Drug Monitoring; Energy Intake; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Glutamine; Growth Hormone; Humans; Hyperplasia; Intestinal Absorption; Intestinal Mucosa; Intestines; Peptides; Randomized Controlled Trials as Topic; Short Bowel Syndrome; Time Factors | 2006 |
4 other study(ies) available for glutamine and oxyntomodulin
| Article | Year |
|---|---|
Glucagon-like peptide-1(7-36)amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat.
Topics: Animals; Aspartic Acid; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glutamine; Hypothalamus, Middle; Male; Microdialysis; Neurotransmitter Agents; Peptide Fragments; Rats; Rats, Wistar | 1995 |
An increase in mucosal insulin-like growth factor II content in postresectional rat intestine suggests autocrine or paracrine growth stimulation.
Topics: Adaptation, Physiological; Animals; Glucagon-Like Peptides; Glutamine; Growth Substances; Ileum; Insulin-Like Growth Factor II; Intestinal Mucosa; Jejunum; Male; Peptide YY; Portal System; Rats; Rats, Sprague-Dawley; Time Factors | 1998 |
Early gastrointestinal regulatory peptide response to intestinal resection in the rat is stimulated by enteral glutamine supplementation.
Topics: Animals; Epidermal Growth Factor; Gastrointestinal Hormones; Glucagon-Like Peptides; Glutamine; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Intestinal Mucosa; Intestines; Male; Peptide YY; Rats; Rats, Sprague-Dawley; Transforming Growth Factor alpha | 1999 |
Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus.
Topics: Animals; Aspartic Acid; Cerebral Cortex; Electroencephalography; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glutamic Acid; Glutamine; Hippocampus; Injections, Intraventricular; Male; Neurons; Peptide Fragments; Peptides; Protein Precursors; Rats; Rats, Wistar; Receptors, Glucagon; Stimulation, Chemical; Ventromedial Hypothalamic Nucleus | 1999 |